-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/HMTQY64cVavMZjxR3mCe5E
January 01, 2020 - media, asthma,
atopic dermatitis, and gastrointestinal tract infection, and chronic
conditions such as obesity
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Stalhandske_71.pdf
February 23, 2008 - trachea, but secretions are plugging the
trachea or there is little air in the respiratory system due to obesity
-
digital.ahrq.gov/sites/default/files/docs/page/ahrq-health-information-technology-portfolio-2012-annual-report.pdf
January 01, 2012 - Low Literacy 7
Teenagers 7
Women* 7
Hypertension 6
Medically Underserved 6
Mental Health/Depression 6
Obesity … Health Information Technology to Support Clinical Decision
Making in Obesity Care PAR-HS-08-270
No … Automating Assessment of Obesity Care Quality PAR-HS-08-270
No Hess, Rachel, M.D. … Online Counseling to Enable Lifestyle-focused Obesity
Treatment in Primary Care PAR-HS-08-270
No Nkoy … Use of Electronic Health Records for Addressing Overweight
and Obesity in Primary Care NOT-HS-08-014
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - The comorbid conditions of interest
include cardiovascular disease, hypertension, type-2 diabetes, obesity … for major diseases such
as hypertension and blood pressure measurements, hyperlipidemia, diabetes, obesity
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Severity.PDF
January 01, 2008 - Other neurological
disorders 8,158,381 0 0.00 1.00 0.06 0.23
CM_OBESE : AHRQ comorbidity measure: Obesity … BREAST DISORDERS 9,662 0.12%
401: PITUITARY & ADRENAL PROCEDURES 3,737 0.05%
403: PROCEDURES FOR OBESITY … AGE>17 WO CC/MC 22,389 0.27%
6191: OR PX FOR OBESITY AGE>17 W CC 3,520 0.04%
6192: OR PX FOR OBESITY … AGE>17 W MCC 592 0.01%
6194: OR PX FOR OBESITY 0-17 WO CC/MC <= 10 *.**%
6195: OR PX FOR OBESITY 0 … -17 W CC <= 10 *.**%
6196: OR PX FOR OBESITY 0-17 W MCC <= 10 *.**%
6220: SKN GRFT&WD DBRD/ENDO,NUT
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Severity.PDF
January 01, 2009 - Other neurological disorders 7,810,762 0 0.00 1.00 0.06 0.23
CM_OBESE : AHRQ comorbidity measure: Obesity … BREAST DISORDERS 9,328 0.12%
401: PITUITARY & ADRENAL PROCEDURES 3,257 0.04%
403: PROCEDURES FOR OBESITY … AGE>17 WO CC/MC 21,000 0.27%
6191: OR PX FOR OBESITY AGE>17 W CC 3,574 0.05%
6192: OR PX FOR OBESITY … AGE>17 W MCC 726 0.01%
6194: OR PX FOR OBESITY 0-17 WO CC/MC 42 0.00%
6195: OR PX FOR OBESITY 0-17 … W CC <= 10 *.**%
6196: OR PX FOR OBESITY 0-17 W MCC <= 10 *.**%
6220: SKN GRFT&WD DBRD/ENDO,NUT,MTB
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Severity.PDF
January 01, 2009 - Other neurological disorders 3,407,146 0 0.00 1.00 0.02 0.14
CM_OBESE : AHRQ comorbidity
measure: Obesity … & BREAST DISORDERS 6,029 0.18%
401: PITUITARY & ADRENAL PROCEDURES 774 0.02%
403: PROCEDURES FOR OBESITY … AGE>17 WO CC/MC 814 0.02%
6191: OR PX FOR OBESITY AGE>17 W CC 69 0.00%
please refer to the section … AGE>17 W MCC 11 0.00%
6194: OR PX FOR OBESITY 0-17 WO CC/MC 178 0.01%
6195: OR PX FOR OBESITY 0-17 … W CC 48 0.00%
6196: OR PX FOR OBESITY 0-17 W MCC 25 0.00%
6220: SKN GRFT&WD DBRD/ENDO,NUT,MTB DIS
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
January 01, 2018 - B
Obesity-Related Morbidity and Mortality: Behavioral Weight Loss Interventions in Adults
The USPSTF … B
Obesity: Screening in Children and Adolescents Age 6 Years and Older
The USPSTF recommends that … clinicians screen for obesity in children and adolescents age
6 years and older and offer or refer them … recommends that primary care professionals individualize the decision to offer
or refer adults without obesity … Preventive Services Task Force | 57
Topic Recommendation
Obesity-Related
Morbidity and Mortality
-
psnet.ahrq.gov/node/49393/psn-pdf
April 01, 2003 - Which End Is Which?
April 1, 2003
Campbell AR. Which End Is Which? PSNet [internet]. 2003.
https://psnet.ahrq.gov/web-mm/which-end-which
The Case
A 39-year-old woman with chronic peri-anal fistulas and infected anal sinuses underwent laparoscopic
diverting colostomy to divert her fecal stream and allow the perine…
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-ok.pdf
November 01, 2017 - EvidenceNow Executive Summary - Oklahoma Cooperative
Oklahoma Cooperative
Oklahoma
EvidenceNOW: Advancing Heart Health in Primary Care is an initiative of the Agency for Healthcare
Research and Quality (AHRQ) to transform health care delivery by building a critical infrastructure
to help smaller primary ca…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cED9Pf3PNUHRUptzXQza-n
April 01, 2016 - The association between obesity and screening mammog-
raphy accuracy. … Obesity, mammography use and accuracy, and
advanced breast cancer risk.
-
effectivehealthcare.ahrq.gov/products/type-2-diabetes-medications-2007/research
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
July 11, 2022 - Recommend low-dose aspirin if the patient has ≥1
of these high-risk factors
Moderatec • Nulliparity
• Obesity … of multiple moderate-risk factors also may be used, such as nulliparity (having never given birth), obesity
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/preeclampsia-screening-april-2017
April 25, 2017 - Other risk factors include nulliparity, obesity, African American race, low socioeconomic status, and … and autoimmune diseases), and multifetal gestation. 4 , 9 Other risk factors include nulliparity, obesity
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
January 10, 2017 - family history of neural tube defects, use of particular antiseizure medications, maternal diabetes, obesity … use of particular antiseizure medications (e.g., valproic acid or carbamazepine), maternal diabetes, obesity
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs026172-obrien-final-report-2022.pdf
January 01, 2022 - assessed the presence of the following clinical risk factors
for developing diabetes: overweight/obesity … Oral presentation at: Wake Forest University Center on Diabetes,
Obesity and Metabolism Annual Meeting
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
September 28, 2021 - multiple moderate-risk factors may be also be used, such as nulliparity (having never given birth), obesity … low-dose aspirin if the patient has ≥1 of these high-risk factors
Moderate c
Nulliparity
Obesity
-
www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/action-alliance-rfi-report-040323_LOCKED.pdf
March 01, 2023 - Patient Safety Action Alliance: Request for Information (RFI) Summary Report
Patient Safety Action Alliance
Request for Information (RFI) Summary Report
March 2023
Background:
At the direction of Secretary Becerra, the Department of Health and Human Services (HHS)
launched a National Healthcare System Action…
-
psnet.ahrq.gov/web-mm/check-anesthesia-machine
August 01, 2006 - factors included the patient's comorbid disease, claustrophobia, inadequate intravenous access, morbid obesity
-
psnet.ahrq.gov/web-mm/air-side-caution
April 21, 2015 - The Case A young woman with morbid obesity was scheduled for cardiac catheterization to evaluate shortness